Ubiquitome to Participate at BIO International Convention 2019
AUCKLAND, New Zealand, May 31, 2019 /PRNewswire/ — New Zealand-based developer Ubiquitome will be exhibiting at the 2019 BIO International Convention in Philadelphia from 3 – 6 June. This event attracts 16,000+ attendees from over 7,000 businesses worldwide, including the leading biotech and pharma companies.
The Convention celebrates globally important innovations in biotech that start with ‘one’: one meeting, one theory, one trial, one breakthrough.
Ubiquitome will be showcasing its breakthrough ‘Personal’ Genomics Device, the Liberty16. Building on the mobile design philosophy of the company’s ground-breaking Freedom4, the Liberty16 brings unprecedented affordability and flexibility to genomic testing.
The Liberty16 comes with built-in lithium ion batteries for two to three hours of mobile running time, as well as Bluetooth paired with an iPhone app, meaning samples can be run and tested in the field.
An open platform with gold standard performance, the Liberty16 is compatible with industry standard consumables and chemistries such as Taqman® and SYBR.
Where: Pennsylvania Convention Center, Philadelphia, PA
When: 3 – 6 June, 2019
Ubiquitome: Booth #4014
For more information on the BIO International Convention, please visit: http://convention.bio.org/.
ABOUT UBIQUITOME
Ubiquitome is a New Zealand-based developer of handheld, cloud-connected, real-time PCR devices. Ubiquitome’s mission is to enable universal access to genomic information through ubiquitous cloud connected, genetic analysis devices. Visit www.ubiquitomebio.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/ubiquitome-to-participate-at-bio-international-convention-2019-300859680.html
SOURCE Ubiquitome
